Compliance report

USEPA. The National Public Water System Program, FY 1988 Compliance Report, Office of Drinking Water, Cincinnati, OH, March 1990. 

According to EPA s National Compliance Report for calendar year 1996 (EPA 1998g), the vast majority of people in the nation received water from systems that had no reported violations of the maximum contaminant level and treatment technique requirements or significant monitoring and reporting requirements. Lead has a maximum permissible level of 15 pg/L delivered to any user of a public water system. Lead and copper are regulated in a treatment technique that requires systems to take tap water samples at sites with lead pipes or copper pipes that have lead solder and/or are served by lead service lines. The water system is required to take treatment steps if the action level (15 pg/L for lead) is exceeded in more than 10% of tap water samples. For calendar year 1996, nearly 6 million people in the United States were served by community water systems that reported maximum contaminant level and treatment technique violations of the Lead and Copper Rule (EPA 1998g). 

USEPA (1993). National Compliance Report. US Environmental Protection Agency, National Public Water System Supervision Program. Washington, DC US Government Printing Office. 

Brief, statistical SRV Test Compliance Summaries are prepared and are provided to higher levels of management. Compliance reports list the total number of SRVs in the area and the total number (and total percentage) that are overdue for testing, if any. They serve as a periodic report card, signifying which process areas are in compliance and which are delinquent. [8]... 

Minor non-compliances reported Conditional approval Compliance Notice issued which specifies (a) Additional information to be supplied (b) Immediate correction of minor non-compliance ) identified Action to be agreed and acted upon by applicant before certificate can be issued... 

For the analysis of the observation period, the data saved in the electronic monitors are transferred via a communicator to a personal computer or to a secure website. With few commands, the patient s medication history can be visualized on the PC screen and then printed as a compliance report. 

The central part of the compliance report is a quantitative and qualitative evaluation of the realtime compliance data. 

Calculation of the shortest and longest intervals between two doses, the percentage of days with correct number of doses taken and the distribution of intervals between doses complete the compliance report. 

The MIAME standard was created by the Functional Genomics Data Society, formerly known as the Microarray Gene Expression Data Society (http // www.mged.org), as an effort to provide standards to specify all the information necessary to describe and interpret unambiguously the results of a microarray experiment (74). The standard defines the contents required for compliance reports but it does not specify the format in which this data should be presented. As a consequence there are a number of different file formats for representing this data, and each public and subscription database has adopted its own format. 

Critical document reviewis done by the PLL team for documents provided by the government, including reports of unusual occurrences or events, safety reviews (including near-miss advisories), reports of nonconformance or non-compliance, reports of test results, audit surveillance inspection reports, daily and weekly operating reports, and campaign reports. The purpose of these reviews is to identity lessons that will be added to the PLL database, update the database as needed, introduce appropriate topics tor discussion at workshops and, if needed, recommend direct actions to secure further information. 

Data saved in electronic monitors may be transferred and collated in larger computers the data transfer may be hard (cable) or soft (telephonic). Patients medication histories can then easily be charted using software that is not sophisticated by today s standards, and hard copy compliance reports can become part of the patient s clinical chart or case report form. 

The central part of the compliance report is a quantitative and qualitative evaluation of the compliance data that was collected real-time. Calendar displays should show the number of daily dose units taken by the patient on ordinary monthly calendars. This form of illustration makes patterns of drug intake easy to see, e.g. an increase in compliance during the last days before the consultation (so-called white-coat compliance ) or the weekend effect (see above). Compliance with prescribed drug holidays, or accuracy of tailing off of therapies, can also be assessed. Understanding these often subtle regimen behaviors may also help the evaluation of reported effects (wanted and unwanted). 

Table compiled from data obtained through http //www.epa-echo.gov/echo/compliance report ici. html... 

Data compiled from http //www.epa-echo.gov/echo/compliance report icis.html. However, it is not clear from the case reports for the listed actions whether each of these twenty enforcement actions contained allegations of commercial use. 

Regulatory compliance reports (including the date and time of notification). 

Provision of specific compliance reports and corrective action (what ). 

---